Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-13.4%Return on Equity
VS
Market
Sector
Industry
History
$ 6.32Close
$ 5.03 - $ 85.23 52-Week Range
Ticker Information
Ticker
NAOVCompany Name
NANOVIBRONIX INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQNANOVIBRONIX INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NAOV - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 40.48M | $ -5.42M | -13.4% |
| 3/31/2025 | $ 35.67M | $ -5.61M | -15.73% |
| 12/31/2024 | $ 627K | $ -3.71M | -590.91% |
| 9/30/2024 | $ 1.87M | $ -3.09M | -164.9% |
| 6/30/2024 | $ 2.84M | $ -2.82M | -99.12% |
| 3/31/2024 | $ 3.5M | $ -3.2M | -91.38% |
| 12/31/2023 | $ 3.99M | $ -3.71M | -93.05% |
| 9/30/2023 | $ 4.69M | $ -4.96M | -105.69% |
| 6/30/2023 | $ 1.17M | $ -5.18M | -445.06% |
| 3/31/2023 | $ 2.2M | $ -5.41M | -245.71% |
Key Performance Insights, Last 5 Years
- NANOVIBRONIX INC's latest trailing twelve months (TTM) ROE stands at -138.14%.
- Over the past 5 years, NANOVIBRONIX INC's average ROE has been -187.61%.
- The median ROE for NANOVIBRONIX INC during this period was -169.03%
- NANOVIBRONIX INC reached its highest ROE over the past 5 years at -13.4%.
- The lowest ROE recorded by NANOVIBRONIX INC in the same timeframe -590.91%
NANOVIBRONIX INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for NANOVIBRONIX INC is calculated as follows: Net Inc. Cmn. [ $ -4.51M ] / Equity [ $ 3.27M ]
(=) ROE [ -138.14% ] NAOV - Return on Equity, Last 5 years
-590.91%
Minimum
Dec 31, 2024
-13.4%
Maximum
Jun 30, 2025
-187.61%
Average
-169.03%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |